220 likes | 529 Views
Hemostasis. Constriction of vessel Aggregation of platelets Clotting: web of fibrin polymers. Platelet Activation. Exposed extracellular matrix at injury binds receptors on platelets Granule release activates additional platelets. Aggregation Of Platelets.
E N D
Hemostasis • Constriction of vessel • Aggregation of platelets • Clotting: web of fibrin polymers
Platelet Activation • Exposed extracellular matrix at injury binds receptors on platelets • Granule release activates additional platelets
Aggregation Of Platelets • Activated platelets adhere strongly to ECM and to each other • Von Willebrandt factor associates platelets with ECM • Fibrinogen cross-links platelets using GPIIb/IIIa receptors • GPIIb/IIIa inhibitors as drugs
Signaling Using Prostaglandins And Thromboxanes • Cyclooxygenase converts arachidonic acid to PGG2 • PGG2 converted to: • Thromboxane A2 (platelets); promotes platelet aggregation • PGI2 (endothelial cells); inhibits platelet aggregation
Membrane Phospholipids Phospholipase A2 Arachidonic Acid Cyclooxygenase Endothelial Cells Platelets PGG2; PGH2 Thromboxane synthase Prostacyclin synthase PGI2 released TxA2 (-) (+) Promote platelet aggregation and vasoconstriction Adenylate cyclase Inhibit platelet aggregation and vasoconstriction
Inhibiting Platelet Aggregation With Aspirin • Aspirin is cyclooxygenase inhibitor • Inhibits platelet aggregation by lowering thromboxane A2 levels
Formation Of Fibrin Network • Conversion of soluble fibrinogen to insoluble fibrin fibers
Structure And Cleavage Of Fibrinogen • Fibrinogen molecule has a2,b2,g2 arrangement • Thrombin cleavage of N-terminal peptides results in fibrin monomer
Formation Of Fibrin Fibers • Monomers associate as half-staggered arrays • Forms “soft clot”
Cross-linking Of Fibrin Monomers (factor XIII) • Isopeptide bonds form between side chains at C-termini • Forms “hard clot”
Pathways For Stimulating Fibrinogen Cleavage • Cascade of proteases that are activated by cleavage • Two pathways activated by different stimuli feed into common pathway
Intrinsic Pathway • Everything needed for pathway contained in blood • Stimulated by contact with negatively charged surface
Extrinsic Pathway • Stimulated by tissue factor (thromboplastin) that is normally buried below endothelium
Common Pathway • Activated factor X cleaves cleaves prothrombin into thrombin • Thrombin cleaves fibrinogen
Structure And Cleavage Of Prothrombin • Two factor X cleavage sites • Thrombin composed of peptides A and B • N terminal region released
Role Of Vitamin K In Clotting • Carboxylation of glutamic acid into Gla required for some clotting factors • Vitamin K is cofactor for modifying enzyme • Dicoumarol and warfarin inhibit clotting through vitamin K cycle
Function Of Gla Residues In Prothrombin Cleavage • Cleavage requires association with phospholipid membrane through Ca2+ bridges • Gla strongly attracts Ca2+
Blood Clotting Disorders • Hemophilia A: inherited deficiency of factor VIII • Von Willebrandt disease: inherited deficiency of vWf
Controlling Blood Clotting • Proteolysis of Factors V and VIII by activated protein c-protein s complex • Inherited disorders protein c, protein s, Factor V
Controlling Blood Clotting Heparin • Heparin increases activity of antithrombin Blood clotting proteases Antithrombin Plasminogen activator • Plasminogen activator protease produces active plasmin Plasminogen Plasmin Fibrin clot Peptides